This study aimed to evaluate the relationship between serum and peritoneal fluid levels of CEA and CA 19-9 and the stage of colorectal cancer (including the presence of peritoneal metastases and the presence of tumor cells on cytologic examination). This evidence concerns the gene CEACAM5 and colorectal cancer.